Industry / France
Liberalisation In OTC Market
July 2008 | Industry NewsBMI anticipates healthy growth in the over-the-counter (OTC) pharmaceutical market in France over the next five years. Driven by a mixture of increased liberalisation and de-reimbursement of prescription pharmaceuticals, the government will hope that increased self-medication will reduce the bulging state
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
